In this work, a new multifunctional nanoplatform (Fe3O4@mSiO2-FA-
CuS-PEG nanocomposite) for magnetic resonance imaging (MRI) and targeted chemo-
photothermal therapy, was firstly fabricated on the basis of magnetic mesoporous
silica nanoparticles (Fe3O4@mSiO2), on which
folic acid (FA) was grafted as the targeting
reagent,
CuS nanocrystals were attached as the photothermal agent, and
polyethylene glycol (PEG) was coupled to improve biocompatibility. The characterization results demonstrated that the fabricated Fe3O4@mSiO2-FA-
CuS-PEG nanocomposites not only showed strong magnetism and excellent MRI performance, but also had a high
doxorubicin (DOX, an anticancer
drug) loading capacity (22.1%). The loaded DOX can be sustainably released, which was
apt to be controlled by pH adjustment and near infrared (NIR)
laser irradiation. More importantly, targeted delivery of the DOX-loaded Fe3O4@mSiO2-FA-
CuS-PEG nanocomposites could be accomplished in HeLa cells via the receptor-mediated endocytosis pathway, and this exhibited synergistic effect of
chemotherapy and
photothermal therapy against HeLa cells under irradiation with a 915 nm
laser. Therefore, the fabricated multifunctional Fe3O4@mSiO2-FA-
CuS-PEG nanocomposite has a great potential in image-guided
therapy of
cancers.